Wells Fargo’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
83,411
-53,462
| -39% | -$909K | ﹤0.01% | 3157 |
|
|
2025
Q1 | $2.67M | Buy |
136,873
+8,871
| +7% | +$173K | ﹤0.01% | 2605 |
|
|
2024
Q4 | $3.17M | Buy |
128,002
+19,158
| +18% | +$475K | ﹤0.01% | 2458 |
|
|
2024
Q3 | $2.67M | Buy |
108,844
+47,091
| +76% | +$1.15M | ﹤0.01% | 2556 |
|
|
2024
Q2 | $1.45M | Buy |
61,753
+14,880
| +32% | +$349K | ﹤0.01% | 2942 |
|
|
2024
Q1 | $1.55M | Buy |
46,873
+9,927
| +27% | +$328K | ﹤0.01% | 2871 |
|
|
2023
Q4 | $1.01M | Sell |
36,946
-61,174
| -62% | -$1.67M | ﹤0.01% | 3101 |
|
|
2023
Q3 | $2.36M | Buy |
98,120
+12,471
| +15% | +$300K | ﹤0.01% | 2487 |
|
|
2023
Q2 | $2.73M | Buy |
85,649
+26,076
| +44% | +$833K | ﹤0.01% | 2499 |
|
|
2023
Q1 | $1.82M | Buy |
59,573
+43,014
| +260% | +$1.32M | ﹤0.01% | 2756 |
|
|
2022
Q4 | $648K | Sell |
16,559
-4,448
| -21% | -$174K | ﹤0.01% | 3279 |
|
|
2022
Q3 | $1M | Sell |
21,007
-54,017
| -72% | -$2.57M | ﹤0.01% | 3047 |
|
|
2022
Q2 | $2.9M | Sell |
75,024
-14,505
| -16% | -$561K | ﹤0.01% | 2373 |
|
|
2022
Q1 | $5.13M | Buy |
89,529
+23,406
| +35% | +$1.34M | ﹤0.01% | 2307 |
|
|
2021
Q4 | $5.27M | Buy |
66,123
+11,336
| +21% | +$903K | ﹤0.01% | 2380 |
|
|
2021
Q3 | $4.77M | Sell |
54,787
-3,483
| -6% | -$303K | ﹤0.01% | 2746 |
|
|
2021
Q2 | $7.5M | Buy |
58,270
+12,636
| +28% | +$1.63M | ﹤0.01% | 2387 |
|
|
2021
Q1 | $3.65M | Buy |
45,634
+7,432
| +19% | +$595K | ﹤0.01% | 2992 |
|
|
2020
Q4 | $3.12M | Buy |
38,202
+5,151
| +16% | +$421K | ﹤0.01% | 3120 |
|
|
2020
Q3 | $814K | Buy |
33,051
+18,508
| +127% | +$456K | ﹤0.01% | 3918 |
|
|
2020
Q2 | $407K | Buy |
14,543
+6,640
| +84% | +$186K | ﹤0.01% | 4351 |
|
|
2020
Q1 | $142K | Buy |
+7,903
| New | +$142K | ﹤0.01% | 4703 |
|